Shaanxi, China

Huijie Bian

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huijie Bian: Innovator in Humanized Anti-BASIGIN Antibodies

Introduction

Huijie Bian is a notable inventor based in Shaanxi, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.

Latest Patents

Huijie Bian holds a patent for "Humanized anti-BASIGIN antibodies and the use thereof." This patent provides a humanized anti-BASIGIN antibody or antigen binding fragment, which includes a heavy chain variable region comprising an amino acid sequence of SEQ ID NO: 1. The patent also describes a composition that includes the humanized anti-BASIGIN antibody, an isolated nucleic acid sequence encoding the antibody, a vector containing the nucleic acid, and a host cell comprising the vector. This innovation has promising applications in therapeutic settings.

Career Highlights

Huijie Bian is affiliated with the Fourth Military Medical University, where he conducts research and development in the field of medical biotechnology. His work has led to advancements in antibody engineering, showcasing his expertise and commitment to improving healthcare solutions.

Collaborations

Huijie Bian collaborates with esteemed colleagues, including Zhinan Chen and Ping Zhu. Their combined efforts contribute to the advancement of research in antibody therapies and related fields.

Conclusion

Huijie Bian's innovative work in humanized anti-BASIGIN antibodies exemplifies the potential of biotechnology to transform medical treatments. His contributions are paving the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…